Pure Global
NCT06351878

TipTraQ Home Sleep Test Validation Study

Validation of a Medical-grade Wearable Device With Interpretable Artificial Intelligence System for the Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS) Screening
PranaQ Pte. Ltd.·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Obstructive Sleep Apnea
Study type
Observational
Sponsor & location
Primary sponsor
PranaQ Pte. Ltd.
Location
Durham, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 28, 2024
End date
Aug 23, 2024
Enrollment
125 participants
Primary outcome

Apnea Hypopnea Index(AHI),Oxygen Desaturation Index(ODI),Total Sleep Time(TST)

Summary

A validation study has been designed to assess the performance of a home sleep test device,
 TipTraQ, for screening sleep apnea. The study involves participants wearing the TipTraQ
 device on their fingertip during a traditional sleep test, known as polysomnography (PSG),
 conducted in a sleep center. The performance of the device will then be evaluated by
 comparing the results from the TipTraQ system with those from the traditional sleep test.

ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06351878
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06351878 through Pure Global AI's free database. This phase not specified trial is sponsored by PranaQ Pte. Ltd. and is currently Recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 125 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.